๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Determinants of the optimal first-line therapy for follicular lymphoma: A decision analysis

โœ Scribed by Rebecca L. Olin; Peter A. Kanetsky; Thomas R. Ten Have; Sunita D. Nasta; Stephen J. Schuster; Charalambos Andreadis


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
165 KB
Volume
85
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A pilot study on the use of the proMACE-
โœ Luca Baldini; Andrea Guffanti; Paolo Gobbi; Mariangela Colombi; Massimo Federico ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 2 views

## Background: The role of intensive conventional dose chemotherapy in advanced low grade non-hodgkin's lymphomas is a matter of debate. the gruppo italiano per lo studio dei linfomi conducted a study to evaluate the efficacy and toxicity of a third-generation polychemotherapeutic regimen, promace-

Chronic myelogenous leukemia in nonlymph
โœ Stefano Sacchi; Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Mary Beth Rios ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 104 KB ๐Ÿ‘ 2 views

## BACKGROUND. The prognoses of patients with chronic myelogenous leukemia in blastic phase (CML-BP) are extremely poor. Treatment of patients with nonlymphoid CML-BP is associated with very low response rates, a median survival of 2-3 months, and significant toxicities. The aim of this study was